John S. Wold

613 total citations
24 papers, 448 citations indexed

About

John S. Wold is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John S. Wold has authored 24 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 8 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John S. Wold's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). John S. Wold is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). John S. Wold collaborates with scholars based in United States and United Kingdom. John S. Wold's co-authors include Luana Fischer, Mildred K. Buening, Daniel S. Longnecker, L.J. Fischer, Lawrence J. Fischer, William J. Steele, Douglas E. Rickert, Douglas M. Morton, R. S. Griffith and David A. Preston and has published in prestigious journals such as The Lancet, Diabetes and Clinical Infectious Diseases.

In The Last Decade

John S. Wold

24 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S. Wold United States 14 236 97 72 70 57 24 448
V. Malerczyk Germany 15 262 1.1× 79 0.8× 35 0.5× 51 0.7× 74 1.3× 46 575
Henry J. Pieniaszek United States 15 132 0.6× 118 1.2× 72 1.0× 113 1.6× 135 2.4× 45 699
Edward J. Mroszczak United States 13 360 1.5× 118 1.2× 132 1.8× 138 2.0× 136 2.4× 26 794
R.P. Stryd United States 9 221 0.9× 69 0.7× 199 2.8× 29 0.4× 37 0.6× 12 542
Robert C. Sonders United States 12 156 0.7× 75 0.8× 40 0.6× 33 0.5× 44 0.8× 18 441
RA Blouin United States 8 227 1.0× 51 0.5× 134 1.9× 31 0.4× 96 1.7× 9 474
Lawrence T. Sennello United States 13 220 0.9× 77 0.8× 40 0.6× 14 0.2× 45 0.8× 26 469
David B. Haughey United States 15 128 0.5× 123 1.3× 25 0.3× 29 0.4× 120 2.1× 34 611
Howard B. Lassman United States 13 149 0.6× 93 1.0× 21 0.3× 43 0.6× 34 0.6× 28 466
Berry J. Kline United States 10 90 0.4× 116 1.2× 37 0.5× 32 0.5× 86 1.5× 17 376

Countries citing papers authored by John S. Wold

Since Specialization
Citations

This map shows the geographic impact of John S. Wold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Wold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Wold more than expected).

Fields of papers citing papers by John S. Wold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Wold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Wold. The network helps show where John S. Wold may publish in the future.

Co-authorship network of co-authors of John S. Wold

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Wold. A scholar is included among the top collaborators of John S. Wold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Wold. John S. Wold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wold, John S., et al.. (1983). LATAMOXEF-ASSOCIATED HYPOPROTHROMBINAEMIA. The Lancet. 322(8346). 408–408. 16 indexed citations
2.
Harada, Yoshio, et al.. (1982). An Evaluation of the Toxicity of Moxalactam in Laboratory Animals. Clinical Infectious Diseases. 4(Supplement_3). S536–S545. 1 indexed citations
3.
Buening, Mildred K. & John S. Wold. (1982). Ethanol-Moxalactam Interactions in Vivo. Clinical Infectious Diseases. 4(Supplement_3). S555–S563. 24 indexed citations
4.
Wold, John S., et al.. (1981). Toxicology of Vancomycin in Laboratory Animals. Clinical Infectious Diseases. 3(Supplement). S224–S229. 23 indexed citations
5.
Wold, John S., et al.. (1981). Toxicology of Vancomycin in Laboratory Animals. Clinical Infectious Diseases. 3(Supplement_2). S224–S229. 71 indexed citations
6.
Wold, John S., et al.. (1978). Hydrolysis of Cefamandole Nafate to Cefamandole in Vivo. The Journal of Infectious Diseases. 137(Supplement). S17–S24. 8 indexed citations
7.
Wold, John S., et al.. (1978). Age-dependent renal accumulation of cephaloridine in the rabbit.. Drug Metabolism and Disposition. 6(1). 87–90. 10 indexed citations
8.
Wold, John S., et al.. (1978). Inhibition of the efflux of organic ions from renal cortical slices. Cellular and Molecular Life Sciences. 34(5). 630–631. 3 indexed citations
9.
Wold, John S., et al.. (1978). Toxicologic Evaluation of Cefamandole Nafate in Laboratory Animals. The Journal of Infectious Diseases. 137(Supplement). S51–S59. 12 indexed citations
10.
Wold, John S., et al.. (1977). Effect of Cefamandole Nafate on the Toxicity of Tobramycin. Antimicrobial Agents and Chemotherapy. 12(4). 465–469. 6 indexed citations
11.
Wold, John S., et al.. (1977). The simultaneous quantitative determination of cephalothin and cefazolin in serum by high pressure liquid chromatography. Clinica Chimica Acta. 78(2). 203–207. 29 indexed citations
12.
Wold, John S., et al.. (1977). Nephrotoxicity of cephaloridine in newborn rabbits: role of the renal anionic transport system.. Journal of Pharmacology and Experimental Therapeutics. 201(3). 778–785. 33 indexed citations
13.
Wold, John S.. (1977). Rapid Analysis of Cefazolin in Serum by High-Pressure Liquid Chromatography. Antimicrobial Agents and Chemotherapy. 11(1). 105–109. 33 indexed citations
14.
Turner, J. R., David A. Preston, & John S. Wold. (1977). Delineation of the Relative Antibacterial Activity of Cefamandole and Cefamandole Nafate. Antimicrobial Agents and Chemotherapy. 12(1). 67–72. 6 indexed citations
15.
Wold, John S., et al.. (1975). DISPOSITION OF CYPROHEPTADINE IN RATS, MICE, AND HUMANS AND IDENTIFICATION OF A STABLE EPOXIDE METABOLITE. Drug Metabolism and Disposition. 3(1). 1–9. 30 indexed citations
16.
Fischer, L.J., John S. Wold, & Douglas E. Rickert. (1973). Structure-activity relationships in drug-induced pancreatic islet cell toxicity. Toxicology and Applied Pharmacology. 26(2). 288–298. 11 indexed citations
17.
Wold, John S., Robert L. Smith, & R. T. Williams. (1973). Species variations in the O-methylation of n-butyl 4-hydroxy-3,5-diiodobenzoate. Biochemical Pharmacology. 22(15). 1865–1873. 2 indexed citations
18.
Wold, John S. & William J. Steele. (1972). Alterations in Liver Nuclear Ribonucleic Acid of Rats Treated with Phenobarbital. Molecular Pharmacology. 8(6). 681–690. 7 indexed citations
19.
Wold, John S. & Luana Fischer. (1972). THE TISSUE DISTRIBUTION OF CYPROHEPTADINE AND ITS METABOLITES IN RATS AND MICE. Journal of Pharmacology and Experimental Therapeutics. 183(1). 188–196. 21 indexed citations
20.
Longnecker, Daniel S., John S. Wold, & Lawrence J. Fischer. (1972). Ultrastructural Study of Alterations in Beta Cells of Pancreatic Islets from Cyproheptadine-Treated Rats. Diabetes. 21(2). 71–79. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Malerczyk Breakdown of academic impact, for papers by Henry J. Pieniaszek Breakdown of academic impact, for papers by Edward J. Mroszczak Breakdown of academic impact, for papers by R.P. Stryd Breakdown of academic impact, for papers by Robert C. Sonders Breakdown of academic impact, for papers by RA Blouin Breakdown of academic impact, for papers by Lawrence T. Sennello Breakdown of academic impact, for papers by David B. Haughey Breakdown of academic impact, for papers by Howard B. Lassman Breakdown of academic impact, for papers by Berry J. Kline
Rankless by CCL
2026